isonicotinamide has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Y; Cui, J; Feng, P; Han, Y; Hu, K; Huang, S; Li, H; Li, L; Tang, G; Wang, J; Yang, S; Zhong, Y | 1 |
| Gao, M; Wang, M; Zheng, QH | 1 |
2 other study(ies) available for isonicotinamide and Alzheimer Disease
| Article | Year |
|---|---|
Novel
Topics: Alzheimer Disease; Animals; Bipolar Disorder; Blood-Brain Barrier; Brain; Cell Line, Tumor; Diabetes Mellitus; Fluorine Radioisotopes; Glycogen Synthase Kinase 3 beta; Humans; Ligands; Neoplasms; Niacinamide; Positron-Emission Tomography; Radiopharmaceuticals; Rats | 2021 |
Synthesis of carbon-11-labeled isonicotinamides as new potential PET agents for imaging of GSK-3 enzyme in Alzheimer's disease.
Topics: Alzheimer Disease; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Glycogen Synthase Kinase 3; Humans; Isotope Labeling; Niacinamide; Positron-Emission Tomography; Radiopharmaceuticals; Solid Phase Extraction | 2017 |